In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff. Click to learn more
Log In

The da Vinci Xi: Does evidence support a price premium?

The da Vinci Surgical System is a surgeon-controlled, minimally invasive robotic platform used to perform a range of complex procedures. The da Vinci Xi was introduced in 2014 to address perceived design shortcomings of its predecessor, the da Vinci Si. However, these improvements come at a higher cost.

Download this article to:

  • Learn what issues the da Vinci Xi was designed to address
  • Explore how the Xi’s modifications impact clinical and operational outcomes
  • Discover whether these outcomes justify the Xi’s price tag